Scientific Advisory Board
What STAR Is
Press Releases and News
The result of years of research, our flagship STAR® technology provides substrate independent, precision engineered, 3D biomaterial scaffolds that enhance the biocompatibility of existing and next generation medical devices.
Healionics Awarded $1.5M SBIR Grant from NIH to Advance Clot-Resistant Synthetic Vascular Graft for Dialysis Patients
Healionics’ Adrienne Oda recognized in
Healionics Awarded $1.3 Million Phase II NIH SBIR Grant to Advance Development of a Next-Generation Hemodialysis Access Device (PDF)
Media & Events
© 2009-2013 Healionics. All rights reserved. U.S. Patent No. 7,972,628. Other U.S. and Foreign Patents Granted or Pending. Site by
These Products are for Research Use Only. Not intended for any animal or human therapeutic or diagnostic use unless otherwise stated.